8 completed, 1 withdrawn. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 8, Withdrawn 1 |
Follow androgel: new trials by email Literature Review of androgel trials Research Report on androgel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening Progesterone, Ibutilide, Testosterone - Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Completed | Indiana University | 73 | 2021-09-02 | 2026-10-20 |
| Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism Testosterone gel 1.62%, Placebo - Type 2 Diabetes Mellitus, Hypogonadism | Phase 4 | Completed | VA Office of Research and Development | 92 | 2019-10-01 | 2026-04-29 |
| Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes Testosterone, Progesterone, Placebo - Long QT Syndrome | Phase 4 | Completed | Indiana University | 14 | 2016-05-01 | 2019-08-28 |
| Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes Testosterone gel, placebo - Hypogonadism, Diabetes | Phase 4 | Withdrawn | Diabetes Center of the Southwest | 2009-08-01 | 2015-08-10 | |
| Effect of Testosterone Replacement on Insulin Resistance Testosterone gel, Placebo for testosterone gel - Metabolic Syndrome, Hypogonadism | Phase 4 | Completed | McGuire Research Institute | 19 | 2007-08-01 | 2012-10-23 |
| Effect of Androgel on Type 2 Diabetic Males With Hypogonadism androgel, androgel 10g, placebo - Diabetes Mellitus Type 2 | Phase 4 | Completed | University at Buffalo | 49 | 2006-07-01 | 2022-02-10 |
| AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment Testosterone gel, Placebo - Depressive Disorder, Major | Phase 4 | Completed | Mclean Hospital | 100 | 2006-04-01 | 2010-11-24 |
| TRADE-Testosterone Replacement and Dutasteride Effectiveness Dutasteride, Testosterone gel, Placebo dutasteride - Hypogonadism, Benign Prostatic Hyperplasia | Phase 4 | Completed | University of Washington | 53 | 2005-03-01 | 2017-12-05 |
| Testosterone Replacement in Metabolic Syndrome and Inflammation Testosterone, Placebo - Hypogonadism, Metabolic Syndrome | Phase 4 | Completed | University of Roma La Sapienza | 82 | 2004-01-01 | 2014-10-28 |
Hypogonadism (6) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Insulin Resistance (2) · Long QT Syndrome (2) · Metabolic Syndrome (2) · Abnormalities, Drug-Induced (1) · Depressive Disorder, Major (1) · Erectile Dysfunction (1) · Obesity (1) · Prostatic Hyperplasia (1) · Risk Reduction Behavior (1) · Torsades de Pointes (1)
Indiana University (2) · Diabetes Center of the Southwest (1) · McGuire Research Institute (1) · Mclean Hospital (1) · University at Buffalo (1) · University of Roma La Sapienza (1) · University of Washington (1) · VA Office of Research and Development (1)
United States (8) · Israel (1) · Italy (1)
James E Tisdale, PharmD (2) · Alvin M Matsumoto, MD (1) · Andrea Lenzi, MD, PhD (1) · Andrea M Isidori, MD, PhD (1) · Harrison G Pope, M.D. (1) · Paresh Dandona, MD (1) · Reina C. Villareal, MD (1) · Sandeep Dhindsa, MBBS (1) · Sonja K Fredrickson, MD (1) · Stuart N Seidman, M.D. (1) · Vincenzo Bonifacio, MD, PhD (1)
PMID 20520285, PMID 21575967, PMID 33020898, PMID 33718653, PMID 35665818, PMID 36171900, PMID 39668628
I01CX001665 (1), R01HL153114 (1)